Interferon Beta-1b (Extavia®)

A Modification Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Contract (Goods)
Duration
0.5 year
Value
£1M
Sector
HEALTH
Published
19 Aug 2022
Delivery
To 15 Feb 2023 (est.)
Deadline
n/a

Concepts

Location

Scotland:

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

Total Quantity or Scope

This modification of contract term from 01/09/2022 to 28/02/2023 is to meet the additional demands of the Scottish Health and Social Care sector during the current Covid-19 pandemic and to maintain necessary supply and remove unnecessary disruption from the Authority at this time in line with Regulation 72(1)(b) of the Public Contracts (Scotland) Regulations 2015

Award Detail

1 Novartis Pharmaceuticals (Frimley)
  • Interferon Beta-1b (Extavia®)
  • Reference: 023050-2022-np91618 (e)-1
  • Value: £1,252,920

CPV Codes

  • 33600000 - Pharmaceutical products

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value in Section V.2.4 covers the thirty-seven (37) months of the framework length and six (6) months extension period of the framework agreement. (SC Ref:703613)

Reference

Domains